» Articles » PMID: 15446586

The Pathogenesis of Neonatal Post-hemorrhagic Hydrocephalus

Overview
Journal Brain Pathol
Date 2004 Sep 28
PMID 15446586
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Hydrocephalus after intraventricular hemorrhage (IVH) has emerged as a major complication of preterm birth and is especially problematic to treat. The hydrocephalus is usually ascribed to fibrosing arachnoiditis, meningeal fibrosis and subependymal gliosis, which impair flow and resorption of cerebrospinal fluid (CSF). Recent experimental studies have suggested that acute parenchymal compression and ischemic damage, and increased parenchymal and perivascular deposition of extracellular matrix proteins--probably due at least partly to upregulation of transforming growth factor-beta (TGF-beta)--are further important contributors to the development of the hydrocephalus. IVH is associated with damage to periventricular white matter and the damage is exacerbated by the development of hydrocephalus; combinations of pressure, distortion, ischaemia, inflammation, and free radical-mediated injury are probably responsible. The damage to white matter accounts for the high frequency of cerebral palsy in this group of infants. The identification of mechanisms and mediators of hydrocephalus and white matter damage is leading to the development of new treatments to prevent permanent hydrocephalus and its neurological complications, and to avoid shunt dependence.

Citing Articles

Neuroinflammatory pathways and potential therapeutic targets in neonatal post-hemorrhagic hydrocephalus.

Schulz L, Varghese A, Michenkova M, Wedemeyer M, Pindrik J, Leonard J Pediatr Res. 2024; .

PMID: 39725707 DOI: 10.1038/s41390-024-03733-z.


Pharmacological Strategies and Surgical Management of Posthemorrhagic Hydrocephalus Following Germinal Matrix-Intraventricular Hemorrhage in Preterm Infants.

Yang Z, Luo T, Dai Y, Duan H, Chong C, Tang J Curr Neuropharmacol. 2024; 23(3):241-255.

PMID: 39248058 PMC: 11808585. DOI: 10.2174/1570159X23666240906115817.


Metabolic Pathways in Hydrocephalus: Profiling with Proteomics and Advanced Imaging.

Davis L, Hwang M Metabolites. 2024; 14(8).

PMID: 39195508 PMC: 11356463. DOI: 10.3390/metabo14080412.


Intervention at an early threshold for post-hemorrhagic ventricular dilatation in preterm infants: a systematic review and meta-analysis.

Blundell P, Abood L, Chakraborty M, Banerjee S World J Pediatr. 2024; 20(8):774-786.

PMID: 39044109 DOI: 10.1007/s12519-024-00827-w.


Structural networking of the developing brain: from maturation to neurosurgical implications.

De Benedictis A, Rossi-Espagnet M, De Palma L, Sarubbo S, Marras C Front Neuroanat. 2023; 17:1242757.

PMID: 38099209 PMC: 10719860. DOI: 10.3389/fnana.2023.1242757.


References
1.
Pang D, Sclabassi R, Horton J . Lysis of intraventricular blood clot with urokinase in a canine model: Part 1. Canine intraventricular blood cast model. Neurosurgery. 1986; 19(4):540-6. DOI: 10.1227/00006123-198610000-00008. View

2.
Back S, Luo N, Borenstein N, Levine J, Volpe J, Kinney H . Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 2001; 21(4):1302-12. PMC: 6762224. View

3.
de la Monte S, Hsu F, Hedley-Whyte E, Kupsky W . Morphometric analysis of the human infant brain: effects of intraventricular hemorrhage and periventricular leukomalacia. J Child Neurol. 1990; 5(2):101-10. DOI: 10.1177/088307389000500206. View

4.
Whitelaw A, Mowinckel M, Abildgaard U . Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?. Acta Paediatr. 1995; 84(8):933-6. DOI: 10.1111/j.1651-2227.1995.tb13795.x. View

5.
Greitz D, Greitz T, Hindmarsh T . A new view on the CSF-circulation with the potential for pharmacological treatment of childhood hydrocephalus. Acta Paediatr. 1997; 86(2):125-32. DOI: 10.1111/j.1651-2227.1997.tb08850.x. View